Novo Nordisk A/S: Transaction in Own Shares

BAGSVÆRD, DENMARK--(Marketwire - June 29, 2009) - Novo Nordisk A/S - Share repurchase programme

On 29 January 2009, Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

Under the programme Novo Nordisk will repurchase B shares for an amount up to DKK 3.0 billion in the period from 29 January 2009 to 5 August 2009.

Since the announcement as of 22 June 2009, the following transactions have been made under the programme:

                  Number of Average purchase  Transaction
                   shares        price        value, DKK
Accumulated, last
announcement      7,949,682                  2,199,283,687
22 June 2009         80,000         284.1900    22,735,200
23 June 2009         80,000         284.3000    22,744,000
24 June 2009         75,000         285.7700    21,432,750
25 June 2009         80,000         282.2400    22,579,200
26 June 2009        120,000         268.3710    32,204,520
Accumulated under
the programme     8,384,682                  2,320,979,357

With the transactions stated above, Novo Nordisk owns a total of 19,176,741 treasury shares, corresponding to 3.1% of the share capital. The total amount of shares in the company is 620,000,000 including treasury shares.

Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs more than 27,900 employees in 81 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For more information, visit novonordisk.com.

Company Announcement no. 37 / 2009

This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

Copyright © Hugin AS 2009. All rights reserved.